• Clinical Evidence

Tight Glucose Control with Minimal Hypoglycemia

Setting: 874-bed regional academic medical center

Objective

This retrospective study evaluates use of EndoTool to achieve tight glucose control for critical care patients receiving intravenous insulin and constant nutrition.

Setting

874-bed regional academic medical center.

Results

  • Roughly half of blood glucose readings <40 mg/dL were associated with procedural errors, either a check more than 30 minutes late or no prior intravenous insulin infusion.
  • Aggregate incidence of hypoglycemia <40 mg/dL was 0.11% of blood glucose readings and 2.9% of patients; when excluding procedural errors, it was 0.05% of blood glucose readings and 1.6% of patients.
  • Mean blood glucose was 119.5 mg/dL (SD 35.9), and median blood glucose was 116 mg/dL.
  • Incidence of hypoglycemia, mean blood glucose, nosocomial infection and length of stay decreased over the study period, given use of EndoTool.

Conclusions

The clinical benefits of tight glucose control in critical care units can be safely achieved with use of EndoTool software.

Objective

This retrospective study evaluates use of EndoTool to achieve tight glucose control for critical care patients receiving intravenous insulin and constant nutrition.

Setting

874-bed regional academic medical center.

Results
  • Roughly half of blood glucose readings <40 mg/dL were associated with procedural errors, either a check more than 30 minutes late or no prior intravenous insulin infusion.
  • Aggregate incidence of hypoglycemia <40 mg/dL was 0.11% of blood glucose readings and 2.9% of patients; when excluding procedural errors, it was 0.05% of blood glucose readings and 1.6% of patients.
  • Mean blood glucose was 119.5 mg/dL (SD 35.9), and median blood glucose was 116 mg/dL.
  • Incidence of hypoglycemia, mean blood glucose, nosocomial infection and length of stay decreased over the study period, given use of EndoTool.
Conclusions

The clinical benefits of tight glucose control in critical care units can be safely achieved with use of EndoTool software.

References

Authors

Steve Cochran, MD; Kelli Dunn, MD; Will Miles, MD.

Source

Presented at American College of Chest Physicians Annual Meeting. Published in Chest, Volume 132, Issue 4, p564A.

Year

2007

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study evaluates use of EndoTool to achieve tight glucose control for critical care patients receiving intravenous insulin and constant nutrition.

Setting

874-bed regional academic medical center.

Results
  • Roughly half of blood glucose readings <40 mg/dL were associated with procedural errors, either a check more than 30 minutes late or no prior intravenous insulin infusion.
  • Aggregate incidence of hypoglycemia <40 mg/dL was 0.11% of blood glucose readings and 2.9% of patients; when excluding procedural errors, it was 0.05% of blood glucose readings and 1.6% of patients.
  • Mean blood glucose was 119.5 mg/dL (SD 35.9), and median blood glucose was 116 mg/dL.
  • Incidence of hypoglycemia, mean blood glucose, nosocomial infection and length of stay decreased over the study period, given use of EndoTool.
Conclusions

The clinical benefits of tight glucose control in critical care units can be safely achieved with use of EndoTool software.

References

Authors

Steve Cochran, MD; Kelli Dunn, MD; Will Miles, MD.

Source

Presented at American College of Chest Physicians Annual Meeting. Published in Chest, Volume 132, Issue 4, p564A.

Year

2007

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.